BR112018068466A2 - lactic acid bacteria composition for the treatment of bacterial vaginal infections by gardnerella vaginalis and, if present, concomitant fungal infections - Google Patents

lactic acid bacteria composition for the treatment of bacterial vaginal infections by gardnerella vaginalis and, if present, concomitant fungal infections

Info

Publication number
BR112018068466A2
BR112018068466A2 BR112018068466A BR112018068466A BR112018068466A2 BR 112018068466 A2 BR112018068466 A2 BR 112018068466A2 BR 112018068466 A BR112018068466 A BR 112018068466A BR 112018068466 A BR112018068466 A BR 112018068466A BR 112018068466 A2 BR112018068466 A2 BR 112018068466A2
Authority
BR
Brazil
Prior art keywords
infections
present
composition
lactic acid
acid bacteria
Prior art date
Application number
BR112018068466A
Other languages
Portuguese (pt)
Inventor
Mogna Giovanni
Original Assignee
Probiotical Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Probiotical Spa filed Critical Probiotical Spa
Publication of BR112018068466A2 publication Critical patent/BR112018068466A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

a presente invenção refere-se a uma composição farmacêutica ou uma composição para um dispositivo médico ou uma composição para um suplemento alimentar (resumidamente, a(s) composição(ões) da presente invenção), com base em bactérias ácido-lácticas pertencentes à espécie lactobacillus fermentum, de uso vaginal e oral para o tratamento simultâneo de infecções, transtornos ou doenças vaginais de origem fúngica e bacteriana. especificamente, a presente invenção refere-se a uma referida composição que compreende excipientes farmacêuticos e/ou de grau alimentar e uma mistura, a qual compreende ou, alternativamente, consiste em pelo menos uma cepa de bactérias pertencentes à espécie lactobacillus fermentum, de uso vaginal e oral para o tratamento simultâneo de infecções, transtornos ou doenças vaginais selecionados a partir de candidíase, vaginite, vulvovaginite ou vaginose bacteriana.The present invention relates to a pharmaceutical composition or a medical device composition or a food supplement composition (briefly, the composition (s) of the present invention) based on lactic acid bacteria belonging to the species. lactobacillus fermentum, for vaginal and oral use for the simultaneous treatment of infections, disorders or vaginal diseases of fungal and bacterial origin. Specifically, the present invention relates to said composition comprising pharmaceutical and / or food grade excipients and a mixture which comprises or alternatively consists of at least one strain of bacteria belonging to the vaginal lactobacillus fermentum species. and oral for the simultaneous treatment of infections, disorders or vaginal diseases selected from candidiasis, vaginitis, vulvovaginitis or bacterial vaginosis.

BR112018068466A 2016-03-24 2017-03-24 lactic acid bacteria composition for the treatment of bacterial vaginal infections by gardnerella vaginalis and, if present, concomitant fungal infections BR112018068466A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITUA20162013 2016-03-24
PCT/IB2017/051710 WO2017163216A1 (en) 2016-03-24 2017-03-24 Lactic acid bacterial composition for the treatment of bacterial vaginal infections by gardnerella vaginalis and, if present, of concurrent fungal infections

Publications (1)

Publication Number Publication Date
BR112018068466A2 true BR112018068466A2 (en) 2019-01-22

Family

ID=59899113

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018068466A BR112018068466A2 (en) 2016-03-24 2017-03-24 lactic acid bacteria composition for the treatment of bacterial vaginal infections by gardnerella vaginalis and, if present, concomitant fungal infections

Country Status (3)

Country Link
BR (1) BR112018068466A2 (en)
CA (1) CA3018035A1 (en)
WO (1) WO2017163216A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20110793A1 (en) 2011-05-09 2012-11-10 Probiotical Spa STRAINS OF PROBIOTIC BACTERIA AND SYNBIOTIC COMPOSITION CONTAINING THEMSELVES INTENDED FOR THE BABY FOOD.
CN110540945B (en) * 2018-05-29 2023-04-25 广东强基药业有限公司 Lactobacillus jensenii and application thereof in preparing vaginal antibacterial drugs
PL241599B1 (en) 2019-11-06 2022-11-07 Sanprobi Spolka Z Ograniczona Odpowiedzialnoscia Spolka Komandytowa New Lactobacillus fermentum PL9 strain and its application

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL210465B1 (en) * 2007-06-04 2012-01-31 Inst Biotechnologii Surowic I Szczepionek Biomed Społka Akcyjna Composition of strains type Lactobacillus and application of the composition of strains type Lactobacillus
EP2158916A1 (en) * 2008-08-27 2010-03-03 Ellen Aktiebolag Administration unit comprising lactic acid bacteria
FI20095550A0 (en) * 2009-05-19 2009-05-19 Bayer Schering Pharma Oy Vaginal delivery system
IT1403661B1 (en) * 2011-01-28 2013-10-31 Probiotical Spa EFFERVESCENT COMPOSITION IN THE SOLID FORM FOR USE IN VAGINAL APPLICATIONS FOR THE TREATMENT OF VAGINAL INFECTIONS.
ITMI20110679A1 (en) * 2011-04-20 2012-10-21 Giovanni Mogna COMPOSITION INCLUDING PROBIOTIC BACTERES ABLE TO RESTORE THE BARRIER EFFECT OF THE STOMACH THAT IS LOST DURING THE PHARMACOLOGICAL TREATMENT OF GASTRICITY.
WO2013093941A2 (en) * 2011-12-21 2013-06-27 Talwar Research Foundation Compositions comprising probiotic lactobacillus strains for improved vaginal health
ITMI20130794A1 (en) * 2013-05-14 2014-11-15 Probiotical Spa COMPOSITION INCLUDING LACTIC BACTERIA FOR USE IN THE PREVENTIVE AND CURATIVE TREATMENT OF BACTERIAL VAGINOSIS.

Also Published As

Publication number Publication date
WO2017163216A1 (en) 2017-09-28
CA3018035A1 (en) 2017-09-28

Similar Documents

Publication Publication Date Title
CO2017013231A2 (en) Compositions comprising a bacterial strain of the genus parabacteroides
CO2017013287A2 (en) Compositions comprising a bacterial strain of the genus Roseburia
BR112018015097A2 (en) composition and reactors
BR112019011702A2 (en) treating a gastrointestinal tract disease with an il-12 / il-23 inhibitor released using an ingestible device
AR106768A1 (en) COMPOSITIONS THAT INCLUDE BACTERIAL VINTAGES
EA201791702A1 (en) THERAPEUTIC TOOLS ON THE BASIS OF GLYCANS AND RELATED METHODS
BR112014019667A2 (en) abeta antibody formulation
BR112018068466A2 (en) lactic acid bacteria composition for the treatment of bacterial vaginal infections by gardnerella vaginalis and, if present, concomitant fungal infections
CL2019002218A1 (en) Triple combination formulations and methods to treat or reduce the risk of cardiovascular disease.
BR112017006416A2 (en) nutritional composition for gastrointestinal environment to provide improved microbiome and metabolic profile
BR112018015367A2 (en) nanofiber oromucosal carriers for therapeutic treatment
BR112017018328A2 (en) tfpi-binding antibody, method for producing and composition comprising the same
PE20190122A1 (en) USE OF BACTERIAL STRAINS BELONGING TO THE LACTOBACILLUS KEFIRI SPECIES IN PEDIATRICS TO GENERATE AND / OR MAINTAIN A STATE OF HOMEOSTASIS
ES2429422R1 (en) Pharmaceutical composition and its use to prepare a medicine for the treatment and prevention of HIV diseases
BR112017012406A2 (en) fixed ratio formulation of insulin glargine / lixisenatide
BR112015029897A2 (en) solid composition for oral administration containing ibandronic acid or a pharmaceutically acceptable salt thereof and vitamin d and process for obtaining said composition
BR112017022653A2 (en) Methods for treating or preventing a disease, rheumatoid arthritis, prostatitis and bph?
CL2017001818A1 (en) Lactic acid bacterium and its use for the treatment of mastitis
BR112018014723A2 (en) bacterial ghosts for cancer treatment
BR112013003064A2 (en) prophylactic or therapeutic agent for non-alcoholic steatohepatitis
WO2019155360A3 (en) Pharmaceutical composition for treating bacterial and viral infections
PE20130308A1 (en) METHODS TO TREAT RECURRING BACTERIAL INFECTIONS
BR112019010792A8 (en) COMPOSITION COMPRISING A BACTERIAL MIXTURE FOR USE IN THE PREVENTION AND IMPROVEMENT OF THE CONDITION OF UNGULATES SUFFERING FROM DISEASES INVOLVING A PARASITIC OR BACTERIAL FOOT INFECTION.
BR112018008835A8 (en) oral pharmaceutical composition, oral pulsatile release pharmaceutical composition, method for treating a disease condition requiring dimethyl fumarate therapy and method for treating multiple sclerosis
BR112022010340A2 (en) PHARMACEUTICAL COMPOSITIONS

Legal Events

Date Code Title Description
B350 Update of information on the portal [chapter 15.35 patent gazette]
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements